All Stories

  1. Atrial Myopathy and Heart Failure: Immunomolecular Mechanisms and Clinical Implications
  2. Correction: Povo-Retana et al. Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment—Progresses in Their Use in Combined Cancer Therapy. Molecules 2024, 29, 331
  3. Potential Beneficial Role of Nitric Oxide in SARS-CoV-2 Infection: Beyond Spike-Binding Inhibition
  4. Fructose-2,6-bisphosphate restores DNA repair activity of PNKP and ameliorates neurodegenerative symptoms in Huntington’s disease
  5. Endogenous LXR signaling controls pulmonary surfactant homeostasis and prevents lung inflammation
  6. Role of NOD1 in atrial myopathy associated with heart failure
  7. Sex differences in cardiac ferroptosis after acute myocardial infarction in wild type and aryl hydrocarbon receptor knockout mice
  8. Reprogramming of the LXRα Transcriptome Sustains Macrophage Secondary Inflammatory Responses
  9. Biomarkers in Contrast-Induced Acute Kidney Injury: Towards A New Perspective
  10. Biomarkers in Contrast-Induced Acute Kidney Injury: Towards a new perspective.
  11. Contribution of Nucleotide-Binding Oligomerization Domain-like (NOD) Receptors to the Immune and Metabolic Health
  12. Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment—Progresses in Their Use in Combined Cancer Therapy
  13. Transcriptomic and lipid profiling analysis reveals a functional interplay between testosterone and growth hormone in hypothyroid liver
  14. 3,4-dimethoxychalcone induces autophagy and reduces neointimal hyperplasia and aortic lesions in mouse models of atherosclerosis
  15. Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond
  16. Immunometabolic actions of trabectedin and lurbinectedin on human macrophages: relevance for their anti-tumor activity
  17. Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance
  18. Defining the metabolic signatures associated with human macrophage polarisation
  19. Editorial: Women in gastrointestinal cancers, volume II: 2022
  20. Trabectedin modulates macrophage polarization in the tumor-microenvironment. Role of KV1.3 and KV1.5 channels
  21. Crosstalk between P2Y receptors and cyclooxygenase activity in inflammation and tissue repair
  22. Inhibition of LXR controls the polarization of human inflammatory macrophages through upregulation of MAFB
  23. Immunometabolic actions of trabectedin and lurbinectedin on human macrophages: Relevance for their antitumor activity
  24. Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction
  25. Free triiodothyronine levels and age influences the metabolic profile and COVID-19 severity parameters in euthyroid and levothyroxine-treated patients
  26. Quantitative Proteomics Analysis Reveals That Cyclooxygenase-2 Modulates Mitochondrial Respiratory Chain Complex IV in Cardiomyocytes
  27. Unraveling the interplay between iron homeostasis, ferroptosis and extramedullary hematopoiesis
  28. COX-2 Expression in Hepatocytes Improves Mitochondrial Function after Hepatic Ischemia-Reperfusion Injury
  29. Functional Crosstalk between PCSK9 Internalization and Pro-Inflammatory Activation in Human Macrophages: Role of Reactive Oxygen Species Release
  30. High-fat diet activates splenic NOD1 and enhances neutrophil recruitment and neutrophil extracellular traps release in the spleen of ApoE-deficient mice
  31. Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 Activation
  32. Use of 11C-acetate PET imaging in the evaluation of advanced atherogenic lesions
  33. The Aryl Hydrocarbon Receptor Ligand FICZ Improves Left Ventricular Remodeling and Cardiac Function at the Onset of Pressure Overload-Induced Heart Failure in Mice
  34. NOD1 splenic activation confers ferroptosis protection and reduces macrophage recruitment under pro-atherogenic conditions
  35. High Fat Diet Activates Splenic NOD1 and Enhances Neutrophil Recruitment and Neutrophil Extracellular Traps Release in the Spleen of ApoE-Deficient Mice
  36. Immuno-Modulation to Treat Common Cardiovascular Diseases
  37. Graphene Particles Interfere with Pro‐Inflammatory Polarization of Human Macrophages: Functional and Electrophysiological Evidence
  38. NOD1 in the interplay between microbiota and gastrointestinal immune adaptations
  39. Beyond classic concepts in thyroid homeostasis: Immune system and microbiota
  40. Crosstalk Between LXR and Caveolin-1 Signaling Supports Cholesterol Efflux and Anti-Inflammatory Pathways in Macrophages
  41. NOD1-Targeted Immunonutrition Approaches: On the Way from Disease to Health
  42. Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases
  43. Chronic treatment with acetaminophen protects against liver aging by targeting inflammation and oxidative stress
  44. Contribution of Extramedullary Hematopoiesis to Atherosclerosis. The Spleen as a Neglected Hub of Inflammatory Cells
  45. Specific Effects of Trabectedin and Lurbinectedin on Human Macrophage Function and Fate—Novel Insights
  46. Deletion or Inhibition of NOD1 Favors Plaque Stability and Attenuates Atherothrombosis in Advanced Atherogenesis
  47. NOD1 deficiency promotes an imbalance of thyroid hormones and microbiota homeostasis in mice fed high fat diet
  48. Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
  49. Innate Immune Receptors, Key Actors in Cardiovascular Diseases
  50. BML‐111 treatment prevents cardiac apoptosis and oxidative stress in a mouse model of autoimmune myocarditis
  51. GRK2 levels in myeloid cells modulate adipose-liver crosstalk in high fat diet-induced obesity
  52. Tumor stem cells fuse with monocytes to form highly invasive tumor-hybrid cells
  53. CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions
  54. Transition of Macrophages to Fibroblast-Like Cells in Healing Myocardial Infarction
  55. Self-defense of macrophages against oxidative injury: Fighting for their own survival
  56. Amyloid Peptide Induced Neuroinflammation Increases the P2X7 Receptor Expression in Microglial Cells, Impacting on Its Functionality
  57. LXR Signaling Regulates Macrophage Survival and Inflammation in Response to Ionizing Radiation
  58. Protective Role of Hepatocyte Cyclooxygenase-2 Expression Against Liver Ischemia-Reperfusion Injury in Mice
  59. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort
  60. Common and Differential Transcriptional Actions of Nuclear Receptors Liver X Receptors α and β in Macrophages
  61. Post-translational modifications of prostaglandin-endoperoxide synthase 2 in colorectal cancer: An update
  62. Endothelial NOD1 directs myeloid cell recruitment in atherosclerosis through VCAM‐1
  63. Benzylamine and Thenylamine Derived Drugs Induce Apoptosis and Reduce Proliferation, Migration and Metastasis Formation in Melanoma Cells
  64. The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras.
  65. Protection against gamma-radiation injury by protein tyrosine phosphatase 1B
  66. Deficiency of NOD1 Improves the β-Adrenergic Modulation of Ca2+ Handling in a Mouse Model of Heart Failure
  67. Correction: Induction of nitric oxide synthase-2 proceeds with the concomitant downregulation of the endogenous caveolin levels (doi:10.1242/jcs.01002)
  68. PGE2 induces apoptosis of hepatic stellate cells and attenuates liver fibrosis in mice by downregulating miR-23a-5p and miR-28a-5p
  69. GQ-11: A new PPAR agonist improves obesity-induced metabolic alterations in LDLr−/− mice
  70. Prostaglandin E2 Impairs P2Y2/P2Y4 Receptor Signaling in Cerebellar Astrocytes via EP3 Receptors
  71. Expression of Concern: Induction of nitric oxide synthase-2 proceeds with the concomitant downregulation of the endogenous caveolin levels. J. Cell Sci. doi: 10.1242/jcs.01002
  72. Mild and Short-Term Caloric Restriction Prevents Obesity-Induced Cardiomyopathy in Young Zucker Rats without Changing in Metabolites and Fatty Acids Cardiac Profile
  73. Cyclooxygenase 2 in liver dysfunction and carcinogenesis: Facts and perspectives
  74. Role of NOD1 in Heart Failure Progression via Regulation of Ca 2+ Handling
  75. Cell Expansion-Dependent Inflammatory and Metabolic Profile of Human Bone Marrow Mesenchymal Stem Cells
  76. NOD1 activation in cardiac fibroblasts induces myocardial fibrosis in a murine model of type 2 diabetes
  77. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice
  78. New thiazolidinediones affect endothelial cell activation and angiogenesis
  79. GM-CSF Enhances Macrophage Glycolytic Activity In Vitro and Improves Detection of Inflammation In Vivo
  80. New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice
  81. Activation of autophagy in macrophages by pro-resolving lipid mediators
  82. New indole-thiazolidine attenuates atherosclerosis in LDLr−/− mice
  83. Metabolic signatures linked to macrophage polarization: from glucose metabolism to oxidative phosphorylation
  84. Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer
  85. HIF-1α and PFKFB3 Mediate a Tight Relationship Between Proinflammatory Activation and Anerobic Metabolism in Atherosclerotic Macrophages
  86. Regulation of MicroRNA 183 by Cyclooxygenase 2 in Liver Is DEAD-Box Helicase p68 (DDX5) Dependent: Role in Insulin Signaling
  87. NOD1, a new player in cardiac function and calcium handling
  88. A labdane diterpene exerts ex vivo and in vivo cardioprotection against post-ischemic injury: Involvement of AKT-dependent mechanisms
  89. NOD1 receptor is up-regulated in diabetic human and murine myocardium
  90. Hepatic Cyclooxygenase-2 Expression Protects Against Diet-Induced Steatosis, Obesity, and Insulin Resistance
  91. NFκB2/p100 Is a Key Factor for Endotoxin Tolerance in Human Monocytes: A Demonstration Using Primary Human Monocytes from Patients with Sepsis
  92. Anti-inflammatory Actions of Acanthoic Acid-Related Diterpenes Involve Activation of the PI3K p110γ/δ Subunits and Inhibition of NF-κB
  93. P727Nucleotide-binding oligomerization domain-containing protein 1-signaling is upregulated in hearts from type 2 diabetic mice
  94. Mitochondrial DAMPs Induce Endotoxin Tolerance in Human Monocytes: An Observation in Patients with Myocardial Infarction
  95. Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD
  96. Pivotal role of protein tyrosine phosphatase 1B (PTP1B) in the macrophage response to pro-inflammatory and anti-inflammatory challenge
  97. Involvement of monocytes/macrophages as key factors in the development and progression of cardiovascular diseases
  98. 2-deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis
  99. Sustained Release of Prostaglandin E2in Fibroblasts Expressing Ectopically Cyclooxygenase 2 Impairs P2Y-Dependent Ca2+-Mobilization
  100. Modulation of Voltage-Dependent and Inward Rectifier Potassium Channels by 15-Epi-Lipoxin-A4 in Activated Murine Macrophages: Implications in Innate Immunity
  101. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma
  102. Progression of liver oncogenesis in the double transgenic mice c-myc/TGF α is not enhanced by cyclooxygenase-2 expression
  103. Prolonged leptin treatment increases transient outward K+ current via upregulation of Kv4.2 and Kv4.3 channel subunits in adult rat ventricular myocytes
  104. Selective Impairment of P2Y Signaling by Prostaglandin E2 in Macrophages: Implications for Ca2+-Dependent Responses
  105. Identification of a novel Pfkfb1 mRNA variant in rat fetal liver
  106. Cyclooxygenase-2 Is a Target of MicroRNA-16 in Human Hepatoma Cells
  107. NOD1 Activation Induces Cardiac Dysfunction and Modulates Cardiac Fibrosis and Cardiomyocyte Apoptosis
  108. Cardiotrophin-1 induces sarcoplasmic reticulum Ca2+ leak and arrhythmogenesis in adult rat ventricular myocytes
  109. Evaluation of epigenetic modulation of cyclooxygenase-2 as a prognostic marker for hepatocellular carcinoma
  110. Propiedades antiinflamatorias de los ácidos grasos poliinsaturados omega-3. Indicaciones en oftalmología
  111. Critical role of the death receptor pathway in the antitumoral effects induced by hispanolone derivatives
  112. Protein Kinase C (PKC)ζ-mediated GαqStimulation of ERK5 Protein Pathway in Cardiomyocytes and Cardiac Fibroblasts
  113. Relevance of the MEK/ERK Signaling Pathway in the Metabolism of Activated Macrophages: A Metabolomic Approach
  114. Labdane diterpenes protect against anoxia/reperfusion injury in cardiomyocytes: involvement of AKT activation
  115. Anti-Inflammatory and Antioxidant Properties of a New Arylidene-Thiazolidinedione in Macrophages
  116. Cot/tpl2 activity is required for TLR-induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression
  117. Transgenic Mice Expressing Cyclooxygenase-2 in Hepatocytes Reveal a Minor Contribution of This Enzyme to Chemical Hepatocarcinogenesis
  118. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C
  119. Benznidazole blocks NF-κB activation but not AP-1 through inhibition of IKK
  120. Retinoid X receptor α controls innate inflammatory responses through the up-regulation of chemokine expression
  121. Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation
  122. Cilastatin Attenuates Cisplatin-Induced Proximal Tubular Cell Damage
  123. Electronegative LDL induction of apoptosis in macrophages: Involvement of Nrf2
  124. ILK mediates LPS-induced vascular adhesion receptor expression and subsequent leucocyte trans-endothelial migration†
  125. Bioactivity of nitrolinoleate: effects on adhesion molecules and CD40–CD40L system☆
  126. Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways
  127. Mice Lacking Thyroid Hormone Receptor β Show Enhanced Apoptosis and Delayed Liver Commitment for Proliferation after Partial Hepatectomy
  128. COX-2 in liver, from regeneration to hepatocarcinogenesis: What we have learned from animal models?
  129. Impairment of Transforming Growth Factor β Signaling in Caveolin-1-deficient Hepatocytes
  130. Vasorelaxant and anti-platelet aggregation effects of aqueous Ocimum basilicum extract
  131. Constitutive COX-2 activity in cardiomyocytes confers permanent cardioprotection
  132. Constitutive expression of cyclo-oxygenase 2 transgene in hepatocytes protects against liver injury
  133. Implication of Glutamate in the Expression of Inducible Nitric Oxide Synthase After Oxygen and Glucose Deprivation in Rat Forebrain Slices
  134. Supression of inflammatory responses by labdane-type diterpenoids☆
  135. Kaurane diterpenes protect against apoptosis and inhibition of phagocytosis in activated macrophages
  136. Selective Impairment of Nuclear Factor-κB-Dependent Gene Transcription in Adult Cardiomyocytes
  137. Atherogenesis takes place in cholesterol-fed rabbits when circulating concentrations of endogenous cortisol are increased and inflammation suppressed
  138. TLR4-Mediated Survival of Macrophages Is MyD88 Dependent and Requires TNF-α Autocrine Signalling
  139. Selective Activation of Liver X Receptors by Acanthoic Acid-Related Diterpenes
  140. Animal models for the study of liver regeneration: role of nitric oxide and prostaglandins
  141. Dispensability and dynamics of caveolin-1 during liver regeneration and in isolated hepatic cells
  142. Identification of conserved domains in the promoter regions of nitric oxide synthase 2: implications for the species-specific transcription and evolutionary differences
  143. Protection against Fas-induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes
  144. Infiltration of Inflammatory Cells Plays an Important Role in Matrix Metalloproteinase Expression and Activation in the Heart during Sepsis
  145. Surgical Excision of Bone Sarcomas Involving the Sacroiliac Joint
  146. Cyclo-oxygenase 2 expression impairs serum-withdrawal-induced apoptosis in liver cells
  147. Specific Contribution of p19ARF to Nitric Oxide-Dependent Apoptosis
  148. The flavonoid quercetin induces apoptosis and inhibits JNK activation in intimal vascular smooth muscle cells
  149. Involvement of mitogen-activated protein kinases in the symbiosis Bradyrhizobium-Lupinus
  150. Cyclooxygenase 2: understanding the pathophysiological role through genetically altered mouse models
  151. The Nonthiazolidinedione PPARγ Agonist L-796,449 Is Neuroprotective in Experimental Stroke
  152. Potentiation of tumor formation by topical administration of 15-deoxy-Δ 12,14 -prostaglandin J 2 in a model of skin carcinogenesis
  153. Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 Cause Potent Neuroprotection after Experimental Stroke through Noncompletely Overlapping Mechanisms
  154. Assessment of a dual regulatory role for NO in liver regeneration after partial hepatectomy: protection against apoptosis and retardation of hepatocyte proliferation
  155. Prostaglandin E 2 promotes migration and adhesion in hepatocellular carcinoma cells
  156. Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate
  157. Nitric Oxide and Cell Signaling: In Vivo Evaluation of NO‐Dependent Apoptosis by MRI and Not NMR Techniques
  158. PGE1-induced NO reduces apoptosis by D-galactosamine through attenuation of NF-κB and NOS-2 expression in rat hepatocytes
  159. A New Family of Synthetic Diterpenes that Regulates Cytokine Synthesis by Inhibiting IκBα Phosphorylation
  160. Attenuation of NF-?B signalling in rat cardiomyocytes at birth restricts the induction of inflammatory genes
  161. Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins
  162. The P34G Mutation Reduces the Transforming Activity of K-Ras and N-Ras in NIH 3T3 Cells but Not of H-Ras
  163. Simultaneous abrogation of NOS-2 and COX-2 activities is lethal in partially hepatectomised mice
  164. Thioacetamide-induced liver regeneration involves the expression of cyclooxygenase 2 and nitric oxide synthase 2 in hepatocytes
  165. Induction of nitric oxide synthase-2 proceeds with the concomitant downregulation of the endogenous caveolin levels
  166. Regional distribution of hyperpolarization-activated current (If) and hyperpolarization-activated cyclic nucleotide-gated channel mRNA expression in ventricular cells from control and hypertrophied rat hearts
  167. Sustained Nitric Oxide Delivery Delays Nitric Oxide-Dependent Apoptosis in Macrophages: Contribution to the Physiological Function of Activated Macrophages
  168. Thromboxane A 2 -Induced Inhibition of Voltage-Gated K + Channels and Pulmonary Vasoconstriction
  169. Induction of Cyclooxygenase-2 Accounts for Restraint Stress-Induced Oxidative Status in Rat Brain
  170. The cyclopentenone 15-deoxy-Δ 12,14 -prostaglandin J 2 binds to and activates H-Ras
  171. The nNOS inhibitor, AR-R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum
  172. Ammonia prevents glutamate-induced but not low K+-induced apoptosis in cerebellar neurons in culture
  173. PKCε is a permissive link in integrin-dependent IFN-γ signalling that facilitates JAK phosphorylation of STAT1
  174. Selective Inhibitors of Cyclooxygenase-2 Delay the Activation of Nuclear Factor κB and Attenuate the Expression of Inflammatory Genes in Murine Macrophages Treated with Lipopolysaccharide
  175. Potentiation of Protein Kinase C ζ Activity by 15-Deoxy-Δ12,14-Prostaglandin J2 Induces an Imbalance between Mitogen-Activated Protein Kinases and NF-κB That Promotes Apoptosis in Macrophages
  176. Presence of methylated arginine derivatives in orthotopic human liver transplantation: Relevance for liver function
  177. H-Ras-specific activation of NF-κB protects NIH 3T3 cells against stimulus-dependent apoptosis
  178. Interleukin-4 and interleukin-10 modulate nuclear factor κB activity and nitric oxide synthase-2 expression in Theiler's virus-infected brain astrocytes
  179. Induction of apoptosis by nitric oxide in macrophages is independent of apoptotic volume decreas
  180. Coexistence of translocated cytochrome c and nitrated protein in neurons of the rat cerebral cortex after oxygen and glucose deprivation
  181. The Increase in TNF-α Levels Is Implicated in NF-κB Activation and Inducible Nitric Oxide Synthase Expression in Brain Cortex after Immobilization Stress
  182. Absence of nuclear factor κB inhibition by NSAIDs in hepatocytes
  183. Nitric oxide and resolution of inflammation
  184. Chronic Stress Induces the Expression of Inducible Nitric Oxide Synthase in Rat Brain Cortex
  185. Protein Kinase Cϵ Is Required for Macrophage Activation and Defense Against Bacterial Infection
  186. Intracellular water motion decreases in apoptotic macrophages after caspase activation
  187. Contribution of cyclooxygenase-2 to liver regeneration after partial hepatectomy
  188. Peroxisome Proliferator-activated Receptor-γ-independent Inhibition of Macrophage Activation by the Non-thiazolidinedione Agonist L-796,449
  189. Up-regulation of TNF-α convertase (TACE/ADAM17) after oxygen–glucose deprivation in rat forebrain slices
  190. Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes
  191. Inhibition of the Nuclear Factor  B (NF- B) Pathway by Tetracyclic Kaurene Diterpenes in Macrophages: SPECIFIC EFFECTS ON NF- B-INDUCING KINASE ACTIVITY AND ON THE COORDINATE ACTIVATION OF ERK AND p38 MAPK
  192. Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor κB-mediated mechanisms
  193. Contribution of Cyclopentenone Prostaglandins to the Resolution of Inflammation Through the Potentiation of Apoptosis in Activated Macrophages
  194. Regulation of cyclooxygenase 2 expression in hepatocytes by CCAAT/enhancer-binding proteins
  195. Mechanisms of the neuroprotective effect of aspirin after oxygen and glucose deprivation in rat forebrain slices
  196. Localisations métastatiques atypiques d’un cancer du rectum
  197. Anti-inflammatory action of type I interferons deduced from mice expressing interferon β
  198. Inhibition of IκB Kinase and IκB Phosphorylation by 15-Deoxy-Δ12,14-Prostaglandin J2 in Activated Murine Macrophages
  199. Inhibitory effect of IGF-I on type 2 nitric oxide synthase expression in Ins-1 cells and protection against activation-dependent apoptosis: involvement of phosphatidylinositol 3-kinase
  200. Inhibition of NOS-2 expression in macrophages through the inactivation of NF-κ B by andalusol
  201. Mechanisms of Nitric Oxide-Dependent Apoptosis: Involvement of Mitochondrial Mediators
  202. Presence of a nitric oxide synthase inhibitor in the graft efflux during reperfusion in human liver transplantation
  203. Protective effect of cyclosporin A and FK506 from nitric oxide-dependent apoptosis in activated macrophages
  204. Down-Regulation of Neuronal Nitric Oxide Synthase by Nitric Oxide After Oxygen-Glucose Deprivation in Rat Forebrain Slices
  205. Expression of cyclooxygenase-2 in foetal rat hepatocytes stimulated with lipopolysaccharide and pro-inflammatory cytokines
  206. Interferon-α/β Inhibits the Apoptosis Induced by Lipopolysaccharide and Interferon-γ in Murine Peritoneal Macrophages
  207. Suppression of HIV-1 infection in linomide-treated SCID-hu-PBL mice
  208. Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices
  209. Differential regulation of nitric oxide synthase mRNA expression by lipopolysaccharide and pro-inflammatory cytokines in fetal hepatocytes treated with cycloheximide
  210. Nuclear factorκB is required for the transcriptional control of type II NO synthase in regenerating liver
  211. Rapid Up-regulation of IκBβ and Abrogation of NF-κB Activity in Peritoneal Macrophages Stimulated with Lipopolysaccharide
  212. Requirement of nitric oxide and calcium mobilization for the induction of apoptosis in adrenal vascular endothelial cells
  213. Nitric oxide induces apoptosis via triggering mitochondrial permeability transition
  214. Absence of NO synthase type II expression in fetal liver from pregnant rats under septic shock conditions
  215. Involvement of nitric oxide synthesis in hepatic perturbations induced in rats by a necrogenic dose of thioacetamide
  216. Expression of the calcium-independent cytokine-inducible (iNOS) isoform of nitric oxide synthase in rat placenta
  217. Regulation of rat liver S-adenosylmethionine synthetase during septic shock: Role of nitric oxide
  218. Up-Regulation of Protein Kinase C-ϵ Promotes the Expression of Cytokine-inducible Nitric Oxide Synthase in RAW 264.7 Cells
  219. Evidence for Common Mechanisms in the Transcriptional Control of Type II Nitric Oxide Synthase in Isolated Hepatocytes
  220. Differential expression pattern of S-adenosylmethionine synthetase isoenzymes during rat liver development
  221. Bacterial lipopolysaccharide antagonizes transforming growth factor ?1-induced apoptosis in primary cultures of hepatocytes
  222. CD53 Antigen and Epidermal Growth Factor Induce Similar Changes in the Pattern of Phorbol Ester Binding in a B Cell Lymphoma
  223. Multiple forms of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase are expressed in perinatal rat liver
  224. Characterization of nitric oxide dependent changes in carbohydrate hepatic metabolism during septic shock
  225. Differential regulation of the expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and pyruvate kinase by cyclic adenosine 3′,5′-monophosphate in fetal and adult hepatocytes
  226. Epidermal growth factor inhibits cytokine-dependent nitric oxide synthase expression in hepatocytes
  227. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels.
  228. Bacterial Lipopeptides Induce Nitric Oxide Synthase and Promote Apoptosis through Nitric Oxide-independent Pathways in Rat Macrophages
  229. Nitric oxide is released in regenerating liver after partial hepatectomy*1
  230. Platelet-activating factor: the effector of protein-rich plasma extravasation and nitric oxide synthase induction in rat immune complex peritonitis
  231. Protein kinase C (PKC)-induced PKC degradation: a model for down-regulation
  232. Characterization of Signals Leading to Clonal Expansion or to Cell Death During Lymphocyte B Cell Activation
  233. From Apoptosis to Autoimmunity: Insights from the Signaling Pathways Leading to Proliferation or to Programmed Cell Death
  234. Nitric Oxide Implication in the Control of Neurosecretion by Chromaffin Cells
  235. CD2-CD48 interaction prevents apoptosis in murine B lymphocytes by up-regulating bcl-2 expression
  236. Cocaine-induced liver injury in mice elicits specific changes in DNA ploidy and induces programmed death of hepatocytes
  237. Protein kinase C V3 domain mutants with differential sensitivities to m-calpain are not resistant to phorbol-ester-induced down-regulation
  238. Induction of nitric oxide release by MRC OX-44 (anti-CD53) through a protein kinase C-dependent pathway in rat macrophages
  239. Relationship between genomic DNA ploidy and parameters of liver damage during necrosis and regeneration induced by thioacetamide
  240. Rat liver messenger ribonucleic acid and enzyme activity of 6- phosphofructo 2-kinase/fructose 2,6-bisphosphatase impairment during the late period of pregnancy
  241. Rat liver messenger ribonucleic acid and enzyme activity of 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase impairment during the late period of pregnancy.
  242. Sulfonylureas activate glycogen phosphorylase and increase cytosolic free-Ca2+ levels in isolated rat hepatocytes
  243. Phorbol esters induce nitric oxide synthase and increase arginine influx in cultured peritoneal macrophages
  244. Signal Transduction Pathways Involved in B-Cell Induction
  245. Circular dichroism analysis of ligand-induced conformational changes in protein kinase C. Mechanism of translocation of the enzyme from the cytosol to the membranes and its implications
  246. Differential calcium mobilization by vasopressin, angiotensin II, gastrin-releasing peptide, and adenosine triphosphate in adult and fetal hepatocytes. Relevance for the activation of calcium-dependent enzymes
  247. Differential calcium mobilization by vasopressin, angiotensin II, gastrin-releasing peptide, and adenosine triphosphate in adult and fetal hepatocytes. Relevance for the activation of calcium-dependent enzymes.
  248. Isoenzymes of carbohydrate metabolism in primary cultures of hepatocytes from thioacetamide-induced rat liver necrosis: Responses to growth factors
  249. Phorbol esters, bombesin and insulin elicit differential responses on the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase system in primary cultures of foetal and adult rat hepatocytes
  250. Inhibition of 6-phosphofructo-2-kinase activity by mercaptopurines
  251. Characterization of 6-phosphofructo-2-kinase from foetal-rat liver
  252. Inactivation of 6-phosphofructo-2-kinase during anaerobiosis in the marine whelk Busycon canaliculatum
  253. Substrate specificity of protein kinase C inhibitors
  254. Lack of translocation of protein kinase C from the cytosol to the membranes in vasopressin-stimulated hepatocytes
  255. Substrate-dependent inhibition of protein kinase C by specific inhibitors
  256. Identification of an anti-A and anti-B blood group glycosyltransferase antibody after incompatible bone marrow transplant
  257. Lack of correlation betwen translocation and biological effects mediated by protein kinase C: an appraisal
  258. Oleate-induced translocation of protein kinase C to hepatic microsomal membranes
  259. Translocation of phosphatidate phosphohydrolase from the cytosol to microsomal membranes in thioacetamide-induced liver tumours in rats
  260. Glucagon-induced changes in fructose 2,6-bisphosphate and 6-phosphofructo-2-kinase in cultured rat foetal hepatocytes
  261. Presence of antibody to A- and B-transferases in minor incompatible bone marrow transplants
  262. Age-related changes in the translocation of phosphatidate phosphohydrolase from the cytosol to microsomal membranes in rat liver
  263. Phorbol 12,13-dibutyrate and mitogens increase fructose 2,6-bisphosphate in lymphocytes. Comparison of lymphocyte and rat-liver 6-phosphofructo-2-kinase
  264. Phorbol ester translocation of protein kinase C in guinea-pig synaptosomes and the potentiation of calcium-dependent glutamate release
  265. Activation of protein kinase C from B lymphocytes by lipid A
  266. Fructose 2,6-bisphosphate in isolated foetal hepatocytes
  267. Expression of the v-src or v-fps oncogene increases fructose 2,6-bisphosphate in chick-embryo fibroblasts. Novel mechanism for the stimulation of glycolysis by retroviruses
  268. Effect of glutamine on fructose 2,6-bisphosphate and on glucose metabolism in HeLa cells and in chick-embryo fibroblasts
  269. Phorbol 12-myristate 13-acetate and insulin increase the concentration of fructose 2,6-bisphosphate and stimulate glycolysis in chicken embryo fibroblasts.
  270. The effect of fructose 2,6-bisphosphate on muscle fructose-1,6-bisphosphatase activity
  271. A problematic enzyme
  272. Difference in glucose sensitivity of liver glycolysis and glycogen synthesis. Relationship between lactate production and fructose 2,6-bisphosphate concentration
  273. Is phosphofructokinase the rate-limiting step of glycolysis?
  274. Biphasic effect of fructose 2,6-bisphosphate on the liver fructose-1,6-bisphosphatase: mechanistic and physiological implications
  275. Specific activation by fructose 2,6-bisphosphate and inhibition by P-enolpyruvate of ascites tumor phosphofructokinase
  276. Mitochondrial Membrane-Bound Hexokinase of Ascites Tumor Cells. Functional Implications of Lysine Residues Studied by Modification with Imidoesters
  277. Measurement of NOS mRNA by Northern Blotting and the Ribonuclease-Protection Assay